期刊文献+

瑞芬太尼复合丙泊酚麻醉在腹腔镜胆囊切除术中的应用 被引量:9

Application remifentanil and propofol during laparoscopic cholecystectomy
原文传递
导出
摘要 目的观察瑞芬太尼复合丙泊酚全凭静脉麻醉在腹腔镜胆囊切除术的应用效果。方法将ASAⅠ~Ⅱ级择期腹腔镜手术患者60例随机分为瑞芬太尼组和芬太尼组,每组30例。比较两组诱导时、术中和清醒时血流动力学参数、苏醒时间、拔管时间和意识状态(OAAS)评分。结果两组患者在诱导时、术中和清醒时SBP、DBP比较差异有统计学意义(P<0.05);MAP、HR和SPO2比较差异无统计学意义(P>0.05),两组患者苏醒、拔管时间和拔管后5min、15min、30min的OAAS评分比较差异有统计学意义(P<0.05)。结论瑞芬太尼复合丙泊酚用于腹腔镜胆囊切除术中麻醉,血流动力学平稳,苏醒快,可控性强,值得临床推广和应用。 Objective To observe the effect of ruifentanyl and Propofol total intravenous anesthesia in laparoscopic cholecystectomy.Methods ASAⅠ~Ⅱ elective laparoscopic surgery were randomly divided into 60 cases of remifentanil and fentanyl groups,n=30.Comparison of two groups induction,intraoperative hemodynamic parameters,and awake,recovery time,extubation time,and consciousness(OAAS) score.Results Two graups in the induction,surgery and awake SBP,DBP the difference was statistically significant(P〈0.05);MAP,HR and SPO2 was no significant difference(P〉0.05),two groups regained consciousness,extubation time,and after extubation 5min,15min,30min of OAAS scores were significantly(P〈0.05).Conclusions Remifentanil and Propofol for laparoscopic cholecystectomy in anesthesia,hemodynamic stability,rapid recovery,control,and is worthy of promotion and application.
作者 陈娟
出处 《医药论坛杂志》 2011年第12期78-80,共3页 Journal of Medical Forum
关键词 瑞芬太尼 丙泊酚 腹腔镜胆囊切除术 Remifentanil Propofol Laparoscopic cholecystectomy
  • 相关文献

参考文献5

二级参考文献24

  • 1张永谦,岳云,冯春生,曲向东.单纯靶控输注雷米芬太尼对BIS和AEPI的影响[J].国际麻醉学与复苏杂志,2006,27(1):29-32. 被引量:27
  • 2张恒文,王俊科.雷米芬太尼、芬太尼、氯胺酮复合丙泊酚用于小儿烧伤和整形手术的比较[J].临床麻醉学杂志,2006,22(5):357-358. 被引量:19
  • 3李家泰.临床药理学(第2版)[M].北京:人民卫生出版社,1997.661-663.
  • 4[2]Wietasch JK,Scholz M,Zinserling J,et al.The performance of a target-controlled infusion of propofol in combination with remifentanil:a clinical investigation with two propofol formulations.Anesth Analg,2006,102(2):430-437.
  • 5[3]Mertens MJ,Olofsen E,Engbers FH,et al.Propofol reduces perioperative remifentanil requirements in a synergistic manner:response surface modeling of perioperative remifentanil-propofol interactions.Anesthesiology,2003,99(2):347-359.
  • 6[4]Hoke JF,Shlugman D,Dershwitz M.Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers.Anesthesiology,1997,87(3):533-541.
  • 7Egan TD,Lemmens HJ,Fiset P,et al.The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers.Anesthesiology,1993,79:881-892.
  • 8Michelsen LG,Hcg CC Jr.The pharmacokieetics of remifentanil.J Clin Anesth,1996,8:679-682.
  • 9Egan TD,Huizinga B,Gupta SK,et al.Remifentanil pharmacokinetics in obese versus lean patients.Anesthesiology,1998,89:562-573.
  • 10Egan TD,Minto CF,Hermann DJ,et al.Remifentanil versus alfentanil:comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers.Anesthesiology,1996,84:821-833.

共引文献95

同被引文献44

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部